List view / Grid view

Nikolay Nikolov MD

First treatment for children with rare vasculitis diseases approved

Rituxan (rituximab) is the first approved treatment for children with…

30 September 2019 | By Rachael Harper (European Pharmaceutical Review)

Rituxan (rituximab) is the first approved treatment for children with rare vasculitis diseases, in which a patient’s small blood vessels become inflamed.

news

First treatment for patients with rare lung disease approved

The FDA has approved the first treatment for interstitial lung…

9 September 2019 | By Rachael Harper (European Pharmaceutical Review)

The FDA has approved the first treatment for interstitial lung disease associated with systemic sclerosis or scleroderma.

Nikolay Nikolov MD

Filter the results

First treatment for children with rare vasculitis diseases approved

First treatment for patients with rare lung disease approved